HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance. (Q45259942)
Jump to navigation
Jump to search
scientific article published on 16 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance. |
scientific article published on 16 April 2011 |
Statements
HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance (English)
Xiaoping Huang
Shuiliang Wang
Choon-Kee Lee